Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Hum Gene Ther ; 25(3): 189-98, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24251946

RESUMO

Dopamine and serotonin are produced by distinct groups of neurons in the brain, and gene therapies other than direct injection have not been attempted to correct congenital deficiencies in such neurotransmitters. In this study, we performed gene therapy to treat knock-in mice with dopamine and serotonin deficiencies caused by a mutation in the aromatic L-amino acid decarboxylase (AADC) gene (Ddc(KI) mice). Intracerebral ventricular injection of neonatal mice with an adeno-associated virus (AAV) serotype 9 (AAV9) vector expressing the human AADC gene (AAV9-hAADC) resulted in widespread AADC expression in the brain. Without treatment, 4-week-old Ddc(KI) mice exhibited whole-brain homogenate dopamine and serotonin levels of 25% and 15% of normal, respectively. After gene therapy, the levels rose to 100% and 40% of normal, respectively. The gene therapy improved the growth rate and survival of Ddc(KI) mice and normalized their hindlimb clasping and cardiovascular dysfunctions. The behavioral abnormalities of the Ddc(KI) mice were partially corrected, and the treated Ddc(KI) mice were slightly more active than normal mice. No immune reactions resulted from the treatment. Therefore, a congenital neurotransmitter deficiency can be treated safely through inducing widespread expression of the deficient gene in neonatal mice.


Assuntos
Descarboxilases de Aminoácido-L-Aromático/genética , Encefalopatias Metabólicas Congênitas/genética , Encefalopatias Metabólicas Congênitas/terapia , Dependovirus/genética , Terapia Genética , Vetores Genéticos/genética , Animais , Animais Recém-Nascidos , Descarboxilases de Aminoácido-L-Aromático/metabolismo , Comportamento Animal , Pressão Sanguínea , Peso Corporal , Encéfalo/imunologia , Encéfalo/metabolismo , Encefalopatias Metabólicas Congênitas/mortalidade , Dependovirus/metabolismo , Modelos Animais de Doenças , Ativação Enzimática , Terapia Genética/efeitos adversos , Terapia Genética/métodos , Vetores Genéticos/administração & dosagem , Vetores Genéticos/metabolismo , Humanos , Injeções Intraventriculares , Camundongos , Camundongos Knockout , Atividade Motora , Neurotransmissores/metabolismo , Distribuição Tecidual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA